| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Potent, Selective Inhibitor of an Emerging Therapeutic Target for Cancer
2019-KRUS-68554 |
Krusemark, Casey John | ||
|
Dr. Emily Dykhuizen is an Assistant Professor of Medical Chemistry and Molecular Pharmacology at Purdue University. Dr. Dykhuizen earned her BA in Biochemistry from Reed College, her PhD in Chemistry from UW-Madison, and her Postdoc in Chromatin Biology from Stanford University. Her research interests include proteomic analysis of chromatin modifying complexes, high throughput screening to identify inhibitors of chromatin regulators, and elucidating the function and genome-wide targeting of proteins containing chromatin binding domains. For additional information, visit Dr. Dykhuizen's Purdue webpage: https://www.mcmp.purdue.edu/faculty/edykhui or her laboratory website: http://www.dykhuizenlab.com/ |
|
